Logo image of AZPN

ASPEN TECHNOLOGY INC (AZPN) Stock Fundamental Analysis

NASDAQ:AZPN - Nasdaq - US29109X1063 - Common Stock - Currency: USD

264.33  +0.03 (+0.01%)

After market: 264.6 +0.27 (+0.1%)

Fundamental Rating

5

AZPN gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 281 industry peers in the Software industry. AZPN has a great financial health rating, but its profitability evaluates not so good. AZPN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

AZPN had positive earnings in the past year.
AZPN had a positive operating cash flow in the past year.
In multiple years AZPN reported negative net income over the last 5 years.
In the past 5 years AZPN always reported a positive cash flow from operatings.
AZPN Yearly Net Income VS EBIT VS OCF VS FCFAZPN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

1.2 Ratios

AZPN's Return On Assets of -0.07% is fine compared to the rest of the industry. AZPN outperforms 60.85% of its industry peers.
Looking at the Return On Equity, with a value of -0.08%, AZPN is in the better half of the industry, outperforming 62.28% of the companies in the same industry.
Industry RankSector Rank
ROA -0.07%
ROE -0.08%
ROIC N/A
ROA(3y)-0.15%
ROA(5y)8.06%
ROE(3y)-0.17%
ROE(5y)17.74%
ROIC(3y)N/A
ROIC(5y)N/A
AZPN Yearly ROA, ROE, ROICAZPN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400 600

1.3 Margins

Looking at the Gross Margin, with a value of 66.07%, AZPN is in line with its industry, outperforming 48.40% of the companies in the same industry.
AZPN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for AZPN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.29%
GM growth 5Y-6.06%
AZPN Yearly Profit, Operating, Gross MarginsAZPN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

9

2. Health

2.1 Basic Checks

AZPN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AZPN has less shares outstanding
AZPN has less shares outstanding than it did 5 years ago.
AZPN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AZPN Yearly Shares OutstandingAZPN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
AZPN Yearly Total Debt VS Total AssetsAZPN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

2.2 Solvency

An Altman-Z score of 8.76 indicates that AZPN is not in any danger for bankruptcy at the moment.
AZPN has a better Altman-Z score (8.76) than 82.21% of its industry peers.
AZPN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 8.76
ROIC/WACCN/A
WACC10.78%
AZPN Yearly LT Debt VS Equity VS FCFAZPN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 3.33 indicates that AZPN has no problem at all paying its short term obligations.
AZPN's Current ratio of 3.33 is fine compared to the rest of the industry. AZPN outperforms 76.87% of its industry peers.
AZPN has a Quick Ratio of 3.33. This indicates that AZPN is financially healthy and has no problem in meeting its short term obligations.
AZPN's Quick ratio of 3.33 is fine compared to the rest of the industry. AZPN outperforms 76.87% of its industry peers.
Industry RankSector Rank
Current Ratio 3.33
Quick Ratio 3.33
AZPN Yearly Current Assets VS Current LiabilitesAZPN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.03% over the past year.
AZPN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.94% yearly.
AZPN shows a small growth in Revenue. In the last year, the Revenue has grown by 7.98%.
AZPN shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.57% yearly.
EPS 1Y (TTM)22.03%
EPS 3Y8.27%
EPS 5Y9.94%
EPS Q2Q%50.36%
Revenue 1Y (TTM)7.98%
Revenue growth 3Y16.7%
Revenue growth 5Y13.57%
Sales Q2Q%18.04%

3.2 Future

Based on estimates for the next years, AZPN will show a small growth in Earnings Per Share. The EPS will grow by 7.03% on average per year.
Based on estimates for the next years, AZPN will show a quite strong growth in Revenue. The Revenue will grow by 8.75% on average per year.
EPS Next Y17.25%
EPS Next 2Y11.33%
EPS Next 3Y10.88%
EPS Next 5Y7.03%
Revenue Next Year7.88%
Revenue Next 2Y7.71%
Revenue Next 3Y7.91%
Revenue Next 5Y8.75%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AZPN Yearly Revenue VS EstimatesAZPN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
AZPN Yearly EPS VS EstimatesAZPN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 37.87, which means the current valuation is very expensive for AZPN.
61.57% of the companies in the same industry are more expensive than AZPN, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.82, AZPN is valued a bit more expensive.
The Price/Forward Earnings ratio is 32.31, which means the current valuation is very expensive for AZPN.
AZPN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AZPN is cheaper than 64.77% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of AZPN to the average of the S&P500 Index (36.21), we can say AZPN is valued inline with the index average.
Industry RankSector Rank
PE 37.87
Fwd PE 32.31
AZPN Price Earnings VS Forward Price EarningsAZPN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

AZPN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AZPN is cheaper than 68.68% of the companies in the same industry.
AZPN's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 54.42
EV/EBITDA 40.9
AZPN Per share dataAZPN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.2
PEG (5Y)3.81
EPS Next 2Y11.33%
EPS Next 3Y10.88%

0

5. Dividend

5.1 Amount

AZPN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ASPEN TECHNOLOGY INC

NASDAQ:AZPN (3/11/2025, 8:00:02 PM)

After market: 264.6 +0.27 (+0.1%)

264.33

+0.03 (+0.01%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-04 2025-02-04/amc
Earnings (Next)N/A N/A
Inst Owners46.66%
Inst Owner Change0%
Ins Owners0.05%
Ins Owner Change-58.82%
Market Cap16.73B
Analysts73.75
Price Target272.83 (3.22%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.49
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-19.3%
Min EPS beat(2)-46.89%
Max EPS beat(2)8.29%
EPS beat(4)3
Avg EPS beat(4)-3.07%
Min EPS beat(4)-46.89%
Max EPS beat(4)14.53%
EPS beat(8)3
Avg EPS beat(8)-11%
EPS beat(12)5
Avg EPS beat(12)-6.65%
EPS beat(16)7
Avg EPS beat(16)-4.89%
Revenue beat(2)1
Avg Revenue beat(2)-9.99%
Min Revenue beat(2)-20.92%
Max Revenue beat(2)0.94%
Revenue beat(4)3
Avg Revenue beat(4)-2.09%
Min Revenue beat(4)-20.92%
Max Revenue beat(4)6.27%
Revenue beat(8)3
Avg Revenue beat(8)-5.74%
Revenue beat(12)4
Avg Revenue beat(12)-13.98%
Revenue beat(16)4
Avg Revenue beat(16)-17.24%
PT rev (1m)3.03%
PT rev (3m)9.8%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.73%
EPS NY rev (1m)0%
EPS NY rev (3m)1.49%
Revenue NQ rev (1m)1.62%
Revenue NQ rev (3m)4.06%
Revenue NY rev (1m)0.33%
Revenue NY rev (3m)0.25%
Valuation
Industry RankSector Rank
PE 37.87
Fwd PE 32.31
P/S 14.84
P/FCF 54.42
P/OCF 51.21
P/B 1.31
P/tB 36.33
EV/EBITDA 40.9
EPS(TTM)6.98
EY2.64%
EPS(NY)8.18
Fwd EY3.09%
FCF(TTM)4.86
FCFY1.84%
OCF(TTM)5.16
OCFY1.95%
SpS17.81
BVpS201.82
TBVpS7.28
PEG (NY)2.2
PEG (5Y)3.81
Profitability
Industry RankSector Rank
ROA -0.07%
ROE -0.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.07%
FCFM 27.27%
ROA(3y)-0.15%
ROA(5y)8.06%
ROE(3y)-0.17%
ROE(5y)17.74%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.29%
GM growth 5Y-6.06%
F-Score8
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 3.91%
Cap/Sales 1.71%
Interest Coverage N/A
Cash Conversion 80.75%
Profit Quality N/A
Current Ratio 3.33
Quick Ratio 3.33
Altman-Z 8.76
F-Score8
WACC10.78%
ROIC/WACCN/A
Cap/Depr(3y)2.54%
Cap/Depr(5y)9.1%
Cap/Sales(3y)1%
Cap/Sales(5y)0.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.03%
EPS 3Y8.27%
EPS 5Y9.94%
EPS Q2Q%50.36%
EPS Next Y17.25%
EPS Next 2Y11.33%
EPS Next 3Y10.88%
EPS Next 5Y7.03%
Revenue 1Y (TTM)7.98%
Revenue growth 3Y16.7%
Revenue growth 5Y13.57%
Sales Q2Q%18.04%
Revenue Next Year7.88%
Revenue Next 2Y7.71%
Revenue Next 3Y7.91%
Revenue Next 5Y8.75%
EBIT growth 1Y51.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year21.32%
EBIT Next 3Y18.97%
EBIT Next 5Y7.32%
FCF growth 1Y194.26%
FCF growth 3Y5.65%
FCF growth 5Y6.4%
OCF growth 1Y203.73%
OCF growth 3Y7.17%
OCF growth 5Y7.36%